Completed within 3-4 weeks
Around 60 different cancer drugs analysed
including ~30 chemotherapy drugs
Clinical response prediction rates of
more than 90%*
Completed within 3-4 weeks
Around 60 different cancer drugs analysed
including ~30 chemotherapy drugs
Clinical response prediction rates of
more than 90%*
PredictRx is Imagen’s pioneering in-vitro diagnostic platform. Our goal is to find the right treatment for you and your cancer’s unique fingerprint. The platform tests for effective treatments directly from live cancer cells, giving oncologists the information they need to better prioritise suitable treatments. This approach can save invaluable time, reduce toxicity and the cost of inefficacious treatments, fully realising the power of personalised therapies to improve clinical outcomes.
PredictRx is Imagen’s pioneering in-vitro diagnostic platform. Our goal is to find the right treatment for you and your cancer’s unique fingerprint. The platform tests for effective treatments directly from live cancer cells, giving oncologists the information they need to better prioritise suitable treatments. This approach can save invaluable time, reduce toxicity and the cost of inefficacious treatments, fully realising the power of personalised therapies to improve clinical outcomes.
predictRx is a 3-stage process that yields a clinical report which can be used to personalise a treatment plan.
A fresh biopsy of the patient’s tumour is delivered to Imagen inside a Nanocool™ kit. The cancer cells are separated and grow in Imagen’s proprietary growth medium until there are enough cells for testing.
A highly advanced, automated fluorescence microscopy screening is carried out to measure drug responses on live tumour cells. Treatment options are compared against our growing, AI-powered biobank of over 150,000 drug responses.
Your personalised results are collated into a sensitivity rating, categorising responses into treatments that work (PPV) and don’t work (NPV). A report is generated and then sent to the clinician.
Ask your oncologist to request predictRx from Imagen.
You are eligible for predictRx if you:
a) Want further treatment
b) Are able to provide a biopsy (or other cancer cells)
Ask your oncologist to request predictRx from Imagen. You are eligible for predictRx if you:
a) Want further treatment
b) Are able to provide a biopsy (or other cancer cells)
Imagen’s phenotypic approach is based on a sophisticated cell death assay that involves automated fluorescence microscopy (High Content Analysis). Our methodology ensures the test is accurate and fast, as well as permitting the screening of a large number of chemotherapy and targeted therapies at once.
Slide me to see how our high content screening platform can visualise drug effectiveness
Our proprietary algorithms compare individual drug responses to a database of over 150,000 patient treatment data points.
Imagen are collecting real-world evidence to continually enhance our approach.
Imagen are collecting real-world evidence to continually enhance our approach.
predictRx accurately predicts clinical response
Our data shows a positive prediction value (PPV) of 89.5% and a negative prediction value (NPV) of 99%.
*More clinical data available, get in touch.
predictRx accurately predicts clinical response
Our data shows a positive prediction value (PPV) of 89.5% and a negative prediction value (NPV) of 99%.
*More clinical data available, get in touch.
Our assay uses computerised microscopy to analyse images and determine the degree of cell death in each well.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
